The fresh reports lift the total number of cases to 30 as of March 24, the Medicines and Healthcare Products Regulatory Agency said in a statement Thursday. The benefits of the shot continue to outweigh the risks, the regulator said.
AstraZeneca’s vaccine, developed with the University of Oxford, is under mounting scrutiny and has faced dwindling support in Europe.
Also Read
The UK agency said that the 30 incidents were out of 18.1 million doses of AstraZeneca vaccine given by March 24. Prior to that, the agency disclosed five cases on March 18, out of 11 million shots.
With the new reports, the rate of incidents with the AstraZeneca shot in the UK is about 1 in 600,000.
There were no reports of the same reactions to the vaccine from Pfizer Inc and BioNTech SE, which is also being used in Britain.
“On the basis of this ongoing review, the benefits of the vaccines against Covid-19 continue to outweigh any risks and you should continue to get your vaccine when invited to do so,” the MHRA said. The AstraZeneca and Pfizer vaccines have shown “very high levels of protection” against Covid-19, the agency said, adding that “all vaccines and medicines have some side effects.”
The UK has one of the world’s fastest-moving vaccine programs, administering shots to more than half of all adults by late March.
New daily Covid cases and deaths have fallen to the lowest levels since September, even as infections surge anew across much of the European Union, where immunisations have lagged.
Earlier this week, the EU drugs regulator said a link between the AstraZeneca vaccine and a rare type of blood clot is possible, identifying at least 62 cases of the condition.
UK adds 4 more countries to travel ban list
The British government is adding four more countries — Bangladesh, Kenya, Pakistan and the Philippines — to its travel ban list amid concerns over new variants of the coronavirus. The Department for Transport said the latest restrictions will take effect in England from April 9.
Under the terms of the travel bans, international visitors who have departed from or travelled through the countries in the preceding 10 days will be refused entry into England.
Sri Lanka temporarily suspends jabs
Sri Lanka has temporarily halted its Covid-19 vaccination programme as there was a delay in securing more AstraZeneca vaccines from the Serum Institute of India, a top health minister has said.
Sri Lanka launched its inoculation programme late January when India gifted 500,000 doses of Oxford-AstraZeneca. The Serum Institute of India (SII) recently suspended exports of the AstraZeneca vaccine.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)